investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Nuclear Architecture and Disease

Tom Misteli

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Stephan Mathas

Charité

Berlin, Germany

Angus Lamond

University of Dundee

Dundee, United Kingdom

Tom Misteli

National Cancer Institute (NIH)

Rockville, United States

Related projects

Erika L Pearce

Tumor-Imposed Glucose Restrictions on T Cells Dampen Immunity

All cancers but non-melanoma skin cancer

Paul Roche

Regulation of MHC Class II Trafficking in Antigen Presenting Cells

All cancers but non-melanoma skin cancer

Neil S Forbes

Targeting Epigenetic Regulators Using Bacterial Macromolecule Delivery

All cancers but non-melanoma skin cancer

Sharon Y. R. Dent

Defining USP22 Functions During Mammalian Development

All cancers but non-melanoma skin cancer

Shiladitya Sengupta

Engineering a supramolecular platinum nanoparticle for pediatric cancer

All cancers but non-melanoma skin cancer

Pediatric oncology or childhood cancer

John A Bartlett

Developing Research Capacity in Africa for Studies on HIV-Associated Malignancies

All cancers but non-melanoma skin cancer

John Koren

Novel Combination Therapeutic Strategies to Ablate Resistance to Hsp90 Inhibitors

All cancers but non-melanoma skin cancer

Richard A Gibbs

The Human Genome Sequencing Center

All cancers but non-melanoma skin cancer

Garrick L Wallstrom

Power analysis tools for biomarker discovery with heterogeneous diseases

All cancers but non-melanoma skin cancer